REGISTERED
on 02 Aug 2022
Last Applicant/ Owned by
125 May Street
Edison
NJ
08837
Serial Number
97263539 filed on 11th Feb 2022
Registration Number
6809081 registered on 02th Aug 2022
Filing Basis
1. use application currently
Disclaimer
NO DATA
AMNIOBAND
Human allograft tissue; human allograft tissue for topical use comprised of tissue from placental membranes; human allograft tissue derived from placental tissue; wound dressings; wound dressings derived from placental tissue; wound coverings made from human placental tissue, namely, coverings for damaged integumental tissue; wound coverings derived from human placental membrane tissue, namely, co Read More
Classification Information
Class [005]
Pharmaceutical Products
Human allograft tissue; human allograft tissue for topical use comprised of tissue from placental membranes; human allograft tissue derived from placental tissue; wound dressings; wound dressings derived from placental tissue; wound coverings made from human placental tissue, namely, coverings for damaged integumental tissue; wound coverings derived from human placental membrane tissue, namely, coverings for damaged integumental tissue
First Use Date in General
05th Jan 2015
First Use Date in Commerce
05th Jan 2015
Mark Details
Serial Number
No 97263539
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 57798-99999
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Aug 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 02th Aug 2022 | REGISTERED-PRINCIPAL REGISTER |
| 17th May 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 17th May 2022 | PUBLISHED FOR OPPOSITION |
| 27th Apr 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 12th Apr 2022 | ASSIGNED TO LIE |
| 08th Apr 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 30th Mar 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 29th Mar 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 29th Mar 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |